To prospectively study the clinico-pathological profile and determine the predictors of renal outcome in patients with RPGN.This study included 40 patients of biopsy proven RPGN. All patients were given induction with i.v. methylprednisolone (0.5 g) for 3 days followed by maintenance with oral Prednisolone (1 mg/kg/day) and six i.v. pulses of cyclophosphamide (0.5 g) given fortnightly followed bymaintenancetherapy with azathioprine (2 mg/kg/day). The outcomes were recorded.